Llp Abingworth - Net Worth and Insider Trading

Llp Abingworth Net Worth

The estimated net worth of Llp Abingworth is at least $275 Million dollars as of 2024-11-13. Llp Abingworth is the 10% Owner of Vera Therapeutics Inc and owns about 2,960,231 shares of Vera Therapeutics Inc (VERA) stock worth over $144 Million. Llp Abingworth is the 10% Owner of Sierra Oncology Inc and owns about 1,314,127 shares of Sierra Oncology Inc (SRRA) stock worth over $72 Million. Llp Abingworth is also the 10% Owner of Soleno Therapeutics Inc and owns about 686,840 shares of Soleno Therapeutics Inc (SLNO) stock worth over $39 Million. Besides these, Llp Abingworth also holds Personalis Inc (PSNL) , Sientra Inc (SIENQ) . Details can be seen in Llp Abingworth's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Llp Abingworth has not made any transactions after 2022-01-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Llp Abingworth

To

Llp Abingworth Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Llp Abingworth owns 11 companies in total, including Personalis Inc (PSNL) , Soleno Therapeutics Inc (SLNO) , and Vaxcyte Inc (PCVX) among others .

Click here to see the complete history of Llp Abingworth’s form 4 insider trades.

Insider Ownership Summary of Llp Abingworth

Ticker Comapny Transaction Date Type of Owner
PSNL Personalis Inc 2020-10-20 10 percent owner
SLNO Soleno Therapeutics Inc 2023-05-08 10 percent owner
PCVX Vaxcyte Inc 2020-06-11 10 percent owner
LIMIT LIMIT 2014-10-21 10 percent owner
LIMIT LIMIT 2018-05-07 10 percent owner
LIMIT LIMIT 2015-07-15 10 percent owner
LIMIT LIMIT 2009-10-16 10 percent owner
LIMIT LIMIT 2022-01-31 10 percent owner
LIMIT LIMIT 2023-01-27 10 percent owner
LIMIT LIMIT 2021-08-25 10 percent owner
LIMIT LIMIT 2022-08-17 10 percent owner

Llp Abingworth Latest Holdings Summary

Llp Abingworth currently owns a total of 5 stocks. Among these stocks, Llp Abingworth owns 2,960,231 shares of Vera Therapeutics Inc (VERA) as of May 18, 2021, with a value of $144 Million and a weighting of 52.28%. Llp Abingworth owns 1,314,127 shares of Sierra Oncology Inc (SRRA) as of January 31, 2022, with a value of $72 Million and a weighting of 26.27%. Llp Abingworth also owns 686,840 shares of Soleno Therapeutics Inc (SLNO) as of June 26, 2020, with a value of $39 Million and a weighting of 14.31%. The other 2 stocks Personalis Inc (PSNL) , Sientra Inc (SIENQ) have a combined weighting of 7.13% among all his current holdings.

Latest Holdings of Llp Abingworth

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VERA Vera Therapeutics Inc 2021-05-18 2,960,231 48.58 143,808,022
SRRA Sierra Oncology Inc 2022-01-31 1,314,127 54.99 72,263,844
SLNO Soleno Therapeutics Inc 2020-06-26 686,840 57.31 39,362,800
PSNL Personalis Inc 2020-10-20 3,753,340 5.23 19,611,202
SIENQ Sientra Inc 2018-05-07 248,049 0.03 6,201

Holding Weightings of Llp Abingworth


Llp Abingworth Form 4 Trading Tracker

According to the SEC Form 4 filings, Llp Abingworth has made a total of 1 transactions in Vera Therapeutics Inc (VERA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vera Therapeutics Inc is the acquisition of 772,727 shares on May 18, 2021, which cost Llp Abingworth around $9 Million.

According to the SEC Form 4 filings, Llp Abingworth has made a total of 1 transactions in Sierra Oncology Inc (SRRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sierra Oncology Inc is the acquisition of 150,000 shares on January 31, 2022, which cost Llp Abingworth around $4 Million.

According to the SEC Form 4 filings, Llp Abingworth has made a total of 1 transactions in Soleno Therapeutics Inc (SLNO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Soleno Therapeutics Inc is the acquisition of 222,222 shares on June 26, 2020, which cost Llp Abingworth around $5 Million.

More details on Llp Abingworth's insider transactions can be found in the Insider Trading History of Llp Abingworth table.

Insider Trading History of Llp Abingworth

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Llp Abingworth Trading Performance

GuruFocus tracks the stock performance after each of Llp Abingworth's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Llp Abingworth is 68.92%. GuruFocus also compares Llp Abingworth's trading performance to market benchmark return within the same time period. The performance of stocks bought by Llp Abingworth within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Llp Abingworth's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Llp Abingworth

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.51 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 11.16 LIMIT LIMIT LIMIT LIMIT LIMIT

Llp Abingworth Ownership Network

Ownership Network List of Llp Abingworth

No Data

Ownership Network Relation of Llp Abingworth

Insider Network Chart

Llp Abingworth Owned Company Details

What does Personalis Inc do?

Who are the key executives at Personalis Inc?

Llp Abingworth is the 10 percent owner of Personalis Inc. Other key executives at Personalis Inc include President Christopher M Hall , Chief Scientific Officer Richard Chen , and Chief Financial Officer Aaron Tachibana .

Personalis Inc (PSNL) Insider Trades Summary

Over the past 18 months, Llp Abingworth made no insider transaction in Personalis Inc (PSNL). Other recent insider transactions involving Personalis Inc (PSNL) include a net sale of 27,013 shares made by Aaron Tachibana , a net sale of 18,966 shares made by Richard Chen , and a net sale of 14,327 shares made by Stephen Michael Moore .

In summary, during the past 3 months, insiders sold 26,443 shares of Personalis Inc (PSNL) in total and bought 3,500,000 shares, with a net purchase of 3,473,557 shares. During the past 18 months, 107,208 shares of Personalis Inc (PSNL) were sold and 3,510,000 shares were bought by its insiders, resulting in a net purchase of 3,402,792 shares.

Personalis Inc (PSNL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Personalis Inc Insider Transactions

No Available Data

Llp Abingworth Mailing Address

Above is the net worth, insider trading, and ownership report for Llp Abingworth. You might contact Llp Abingworth via mailing address: 38 Jermyn Street, London X0 Sw1y 6dn.